Skip to content

BioClinMS

Active Private limited companyfounded 2003active for 23 yearsCoquiniestraat 232, 7700 MouscronKBO/BCE: BE 0479.891.266

Lifetime

20 annual accounts with figures on one time axis, 23 filings since 2003
peak of €690,325 in 2025
€690,325▲ 0.3%
peak of €298,495 in 2025
€298,495▲ 3.8%
peak of €1.1m in 2024
€792,301▼ 30.7%
€3.2m▲ 10.8%
Board1 name since 2003
1 director
Documentsfilings and deeds
26-06-202635 days before the deadline
2025micro format
Dividend €648,697Equity from €1.1m to €792,301

Key points

from the 2025 annual accounts

Equity

€792,301 ▼ 30.7%
1.12024+0.3Profit-0.6Dividend0.82025

BioClinMS paid out €648,697 in dividends. That is 217% of the 2025 profit.

Debts

€3.2m 80% of the balance sheet
Financial debts 70%Suppliers 0%Taxes and wages 3%Other 27%

Of this, €954,656 falls due within a year.

Liquidity

0.69 was 1.77 in 2024

Short-term debts rose from €392,157 to €954,656.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 2,615 companies had the same profile as BioClinMS has now. Each dot stands for 7 companies, two years later.

97.3%
were still trading
2.0%
stopped another way
0.7%
went bankrupt
  • Small
  • 20 years or older
  • solvency 10 to 30%
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,994 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 2,615 companies, not a prediction for BioClinMS. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 31-03-2003
Board & ownership

Recent changes

Company renamed to BioClinMS changes role from manager to director · Discharge granted to (manager) · Legal-form conversion: from private limited company (pre-2019) to private limited company · General meeting of 18-12-2023 · Gazette deed
First establishment Coquiniestraat 232, Mouscron
Capital decrease of €162,900 to €18,600 The capital fell from €181,500 to €18,600 · Gazette deed
Capital increase of €162,900 to €181,500 The capital rose from €18,600 to €181,500 · General meeting of 03-02-2014 · Gazette deed
All 35 events

Official details

Source: KBO
Status
Active since 31-03-2003Normal situation
Activity
Medical imaging and medical laboratoriesNACE 869101 activity on the establishment unitFrom the articles, 6 activities
Establishment unit
2.354.708.3557700 Mouscron, since 01-01-2019
Financial year end
31 December
Peppol
Not found in the Peppol Directory
Company details

Annual accounts 2025

≈ €1.4mestimated
€4.0m▼ 0.9%
Filing
Filed on 26-06-2026, 35 days before the end of the filing period
Financials

Insights on BioClinMS

BioClinMS files the micro format. That format states no turnover. The gross margin rose from €247,208 in 2006 to €690,325 in 2025.

The balance sheet grew most from 2019 to 2021 through fixed assets, financed with long-term debt.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about BioClinMS

What is the company number of BioClinMS?
The company number of BioClinMS is 0479.891.266. The VAT number is the same number with BE in front: BE 0479.891.266.
Where is BioClinMS based?
The registered office is at Coquiniestraat 232, 7700 Mouscron.Company details
What does BioClinMS do?
According to the KBO register, the main activity of the establishment unit is medical imaging and medical laboratories (NACE 86910).
What is the legal form of BioClinMS?
BioClinMS is a private limited company (BV).
When was BioClinMS founded?
BioClinMS was founded on 31-03-2003.
Is BioClinMS still active?
Yes, BioClinMS is an active enterprise in the KBO register.
What is the turnover of BioClinMS?
The turnover in financial year 2025 is about €1.4m. This figure is estimated from the gross margin of €690,325 and 1,019 comparable companies of the same size. It probably lies between €960,000 and €2.0m. It is a rough estimate.Financials
Is BioClinMS profitable?
In financial year 2025, BioClinMS made a profit of €298,495.
Where can I find the annual accounts of BioClinMS?
BioClinMS filed 23 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of BioClinMS due?
BioClinMS must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.